4th Quarter - Termination
ACCELERON PHARMA INC for ACCELERON PHARMA INC
Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Nov 26, 2021
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
The client is engaging on H.R. 3 - Lower Drug Costs Now Act and prescription drug pricing legislation generally.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREG CHESMORE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.